Figures & data
Table 1. Blood parameters.
Figure 2. (A) Representative hematoxylin and eosin (H&E) staining for the thoracic aortas (400× magnification). (B) Quantification of lesion area. (C) mRNA quantification for the antioxidant genes in aorta. Data are expressed as mean ± SEM (for each group, n = 10). ##P < 0.01 compared with control (CTL) rats; *P < 0.05 and **P < 0.01 compared with atherosclerotic (As) rats.
![Figure 2. (A) Representative hematoxylin and eosin (H&E) staining for the thoracic aortas (400× magnification). (B) Quantification of lesion area. (C) mRNA quantification for the antioxidant genes in aorta. Data are expressed as mean ± SEM (for each group, n = 10). ##P < 0.01 compared with control (CTL) rats; *P < 0.05 and **P < 0.01 compared with atherosclerotic (As) rats.](/cms/asset/1efcb6e6-ce12-4f66-b5b0-efc2f2eda6e0/iphb_a_551776_f0002_b.gif)
Figure 3. (A) Representative hematoxylin and eosin (H&E) staining for the livers (400× magnification). (B) Lipid profile in the livers. (C) mRNA quantification for the antioxidant genes. (D) mRNA quantification for the genes in fatty acid oxidation. Data are expressed as mean ± SEM (for each group, n = 10). #P < 0.05 and ##P < 0.01 compared with control (CTL) rats; *P < 0.05 and **P < 0.01 compared with atherosclerotic (As) rats.
![Figure 3. (A) Representative hematoxylin and eosin (H&E) staining for the livers (400× magnification). (B) Lipid profile in the livers. (C) mRNA quantification for the antioxidant genes. (D) mRNA quantification for the genes in fatty acid oxidation. Data are expressed as mean ± SEM (for each group, n = 10). #P < 0.05 and ##P < 0.01 compared with control (CTL) rats; *P < 0.05 and **P < 0.01 compared with atherosclerotic (As) rats.](/cms/asset/057a3590-057e-4958-852a-d4d2c2797cdc/iphb_a_551776_f0003_b.gif)